KC
Kali Charan Das Khandelwal
About Kali Charan Das Khandelwal
Data last updated:
Kali Charan Das Khandelwal is a Director at Rasik Remedies Private Limited (since 2018), Director at Safpure Lifesciences Private Limited (since 2020) and Director at Rex Remedies Distributors Private Limited (since 2018). The companies operate in Healthcare, Travel and Hospitality and Pharma. The 3 current companies with reported revenue have a combined latest revenue of ₹106 Cr; the largest is Rasik Remedies Private Limited at ₹76.75 Cr (FY 2024). Earlier, Kali Charan Das Khandelwal was a Partner at Krishna Mahima Hotels And Estates Llp (2014–2024) and Director at Kodiya Enterprises Private Limited (2019–2024).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Rasik Remedies Private Limited U51397RJ2009PTC029310 | Director | 22 Dec 2018 | 2009 | ₹76.75 Cr (FY 2024) | Active |
| Safpure Lifesciences Private Limited U24232RJ2013PTC042203 | Director | 05 Mar 2020 | 2013 | ₹29.57 Cr (FY 2025) | Active |
| Rex Remedies Distributors Private Limited U74999RJ2017PTC058886 | Director | 27 Feb 2018 | 2017 | ₹15,452 (FY 2023) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Partner | 10 Jan 2014 | 2014 | Active | ||
| Kodiya Enterprises Private Limited U52100RJ2019PTC067459 | Director | 19 Dec 2019 | 2019 | ₹38.33 Cr (FY 2025) | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Kali Charan Das Khandelwal
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Kali Charan Das Khandelwal
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Kali Charan Das Khandelwal
Kali Charan Das Khandelwal currently holds 3 directorships: Rasik Remedies Private Limited (Director, since 22 Dec 2018, revenue ₹76.75 Cr (FY 2024)); Safpure Lifesciences Private Limited (Director, since 05 Mar 2020, revenue ₹29.57 Cr (FY 2025)); Rex Remedies Distributors Private Limited (Director, since 27 Feb 2018, revenue ₹15,452 (FY 2023)).
Kali Charan Das Khandelwal was first appointed on 10 Jan 2014 as Partner at Krishna Mahima Hotels And Estates Llp. The most recent appointment on record is 05 Mar 2020 at Safpure Lifesciences Private Limited.
The 3 current companies of Kali Charan Das Khandelwal that report revenue have a combined latest revenue of ₹106 Cr: Rasik Remedies Private Limited ₹76.75 Cr (FY 2024); Safpure Lifesciences Private Limited ₹29.57 Cr (FY 2025); Rex Remedies Distributors Private Limited ₹15,452 (FY 2023).
Kali Charan Das Khandelwal held 2 earlier board appointments: Krishna Mahima Hotels And Estates Llp (Partner, 10 Jan 2014 to 31 Jan 2024); Kodiya Enterprises Private Limited (Director, 19 Dec 2019 to 14 Feb 2024).
The current boards of Kali Charan Das Khandelwal's companies include Gaurav Khandelwal (Rasik Remedies Private Limited), Kishan Gopal Khandelwal (Rasik Remedies Private Limited), Narendra Kumar Khandelwal (Rasik Remedies Private Limited), Poonam Khandelwal (Rasik Remedies Private Limited), Saroj Khandelwal (Rasik Remedies Private Limited), Sourabh Khandelwal (Rasik Remedies Private Limited), among others.